in

Denosumab Raises Hypocalcemia Risk in Chronic Kidney Disease

Source link : https://www.newshealth.biz/health-news/denosumab-raises-hypocalcemia-risk-in-chronic-kidney-disease/

TOPLINE: Denosumab treatment for osteoporosis raises the risk for hypocalcemia, which worsens with advancing stages of chronic kidney disease (CKD), in those with CKD–Mineral and Bone Disorder (CKD-MBD) and in those undergoing dialysis. METHODOLOGY: There is a paucity of data regarding treatments for osteoporosis in patients with advanced CKD, who often develop CKD-MBD, a clinical […]

Author : News Health

Publish date : 2024-11-21 12:05:32

Copyright for syndicated content belongs to the linked Source.

Türkiye to face Hungary in EuroBasket 2025 qualifiers Friday in Istanbul

Voices of Optimism: Trump Supporters Share Their Hopes for a Second Presidency